Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer

Autor: Cabezas-Camarero, S., Puebla, F., Subhi-Issa, A.I., Sanz-Ortega, J., Pérez-Segura, Pedro
Zdroj: In Oral Oncology December 2018 87:204-206
Databáze: ScienceDirect